PEER-REVIEWED PUBLICATION

2025

Effects of linsitinib on M22 and IGF-1-treated 3D spheroids of human orbital fibroblasts

A tensile test divider icon

Hikage F, Suzuki M, et al.

Scientific Reports

Sapporo Medical University School of Medicine

RESEARCH SUMMARY
This study investigates the role of IGF-1 receptor inhibition in Graves’ orbitopathy (GO) using three-dimensional (3D) spheroids derived from human orbital fibroblasts obtained from patients with and without GO. Treatment with IGF-1 and the stimulatory TSH receptor antibody M22 significantly increased mitochondrial and glycolytic activity and induced marked stiffening of 3D spheroids, accompanied by up-regulation of extracellular matrix proteins and profibrotic markers. Linsitinib, a selective IGF-1R/IR inhibitor, effectively suppressed M22-induced increases in spheroid stiffness despite having minimal effects on spheroid size. Changes in stiffness closely correlated with altered expression of collagens, fibronectin, lysyl oxidase, connective tissue growth factor, and matrix metalloproteinases, indicating mechanically driven fibrogenesis. These findings demonstrate that mechanical phenotyping of 3D orbital fibroblast spheroids provides a sensitive in vitro platform for studying GO pathogenesis and evaluating antifibrotic therapeutic strategies. :contentReference[oaicite:1]{index=1}
CellScale hexagons, without text

CELLSCALE INSTRUMENT USED

MicroTester

A MicroTester was used to quantify the mechanical stiffness of living 3D orbital fibroblast spheroids via controlled micro-indentation. Individual spheroids were compressed using a microscale indenter until reaching approximately 50% deformation over a 20-second interval, while force and displacement were continuously recorded. The resulting force-displacement data were normalized by spheroid semi-diameter to derive a stiffness index, enabling quantitative comparison across treatment conditions. This microscale mechanical testing approach was essential for detecting IGF-1- and M22-induced fibrotic stiffening and for demonstrating the inhibitory effect of linsitinib on GO-related biomechanical remodeling.
AUTHORS

Fumihito Hikage; Megumi Suzuki; Tatsuya Sato; Araya Umetsu; Toshifumi Ogawa; Nami Nishikiori; Masato Furuhashi; Hiroshi Ohguro; Megumi Watanabe.

PUBLICATION DETAILS
JOURNAL

Scientific Reports

YEAR

2025

INSTITUTIONS

Sapporo Medical University School of Medicine

COUNTRIES

Japan

INSTRUMENT USED

MicroTester

TESTING METHODS

Hydrated and Temperature Controlled TestingIndentation TestingMicro-Mechanical TestingUltra Low Force Testing

RESEARCH APPLICATIONS

Drug Screening & Drug Delivery MechanicsFibrosis & Tissue RemodelingMechanotransductionMicrotissue and Spheroid MechanicsOrgan-On-A-Chip Systems

Related Publications:

Instrument Used:
Year:
Testing Method:
Research Application:
Country:

Contact Sales

Product of Interest:
CellScale hexagon shapes